There was a problem loading this presentation. You may not have permission to view it.

You do not have permission to view this presentation.

Basics of immuno-oncology


An error occurred while loading this content.

Please refresh the page to try again.

Refresh Now
You previously started this content
Login or join to view
Click to Play

Basics of immuno-oncology

The texts for this project were developed in cooperation with the members of our Advisory Board.
• Prof. Dr. med. Salah Eddin Al-Batran, Frankfurt am Main (Germany)
• Prof. Dr. med. Diana Lüftner, Berlin (Germany)
• Amel M’sadek, (Oncology Nurse and Member of the French Association of Oncology Nurses (AFIC)), Rennes Cedex (France)
• Marion Mecklenborg, (Oncology Nurse), Bremen (Germany)
• Dr. ssa. Alessandra Milani, (Oncology Nurse), Milan (Italy)
• Maria Paz Fernández Ortega, (Oncology Nurse), Barcelona (Spain)
• Julia Williams, (Oncology Nurse), Berks (England)

In this module, we present different immunotherapy techniques, their therapeutic potential and the history of this type of treatment.

1. Borghaei H et al;  Immunotherapy of cancer. Eur J Pharmacol. 2009; 625:41-54

2. Kapoor A et al: Malignancy in kidney transplant recipients. Drugs 68, 2008, S. 11–19

3. C. V. Ichim: Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. In: J Transl Med 3, 2005; 8;3(1):8.

4. P. Ehrlich: Über den jetzigen Stand der Karzinomforschung. In: Ned Tijdschr Geneeskd 5, 1909, S. 273–290..

5. Hanahan Weinber D et al; Hallmarks of cancer: the next generation; Cell (2011); 144 (5): 646-74;   

6. Baxevanis CN et al; Therapeutic cancer vaccines: a long and winding road to success; Expert Rev Vaccines. 2014 Jan;13(1):131-44

7. Dolan DE et al; PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy; Cancer Control (2014); 21(3): 231-7



Responsible for the content: © 2015 KWHC GmbH, Alewinstr. 13, 29525 Uelzen (Germany). The image sources can be found at:

Latest expert presentations

View more